about
Therapeutic education in coronary heart disease: position paper from the Working Group of Exercise Rehabilitation and Sport (GERS) and the Therapeutic Education Commission of the French Society of Cardiology[Acute atrio-ventricular block in sickle cell anemia].Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohort.B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.Clinical applications of B-type natriuretic peptide (BNP) testing.State of the art: using natriuretic peptide levels in clinical practice.Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.Therapeutic patient education in heart failure: do studies provide sufficient information about the educational programme?Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial.Non-vitamin K antagonist oral anticoagulants and heart failure.Changes in One-Year Mortality in Elderly Patients Admitted with Acute Myocardial Infarction in Relation with Early Management.Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme.Brain natriuretic peptide usefulness in very elderly dyspnoeic patients: the BED study.[Silent Q fever endocarditis. Report of a case]Socioeconomic factors and mortality in diastolic heart failure.First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.[Stress ultrasonography under low doses of dobutamine, contractile reserve and dilated cardiomyopathy]Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol.Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease.[Importance of therapeutic education in the multidisciplinary management of heart failure]Therapeutic patient education and all-cause mortality in patients with chronic heart failure: a propensity analysis.Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO).A gray zone assigned to inconclusive results of quantitative diagnostic tests: Application to the use of brain natriuretic peptide for diagnosis of heart failure in acute dyspneic patients.Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation: a hormonal study.Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching.[Therapeutic education for patients with heart failure, a performance factor].Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.Two-year outcome of patients after a first hospitalization for heart failure: A national observational study.Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry.Perception of therapeutic patient education in heart failure by healthcare providers.[Medico-economic impact of an innovative management of CHF by HF unit].Impact de l’éducation thérapeutique sur les habitudes de vie : perception des patients et de leurs prochesImpact of heart failure management unit on heart failure-related readmission rate and mortality[Perception and understanding chronic heart failure by the patient. The impact of therapeutic education on the level of knowledge of patients. About 350 cases][Paralysing hypokalemic thyrotoxicosis][Utility of BNP measurement in the emergency room in patients with suspected unstable angina with a normal ECG][Brain natriuretic peptide and heart failure]
P50
Q26864293-3580A3CC-5476-437D-A944-235219AD12AEQ33164790-EE199420-6E2F-4550-A71B-F129E2036EB8Q33491891-7FDCF8FF-746E-4156-A3B9-A397C91FDA75Q35000296-9A4B75C1-0BE1-465C-A960-39A1205A2F3BQ35548836-4DC93B9E-A5C5-4C8B-A178-D770FE59728AQ37257460-A55C48A6-8502-423A-861A-6484B27FC35DQ38148873-0AAAD277-300A-4C30-97BB-78358C7F606CQ38175561-DC5D78F2-F6BE-4EA5-841E-F64D1EB3F696Q38194714-FDD51636-8871-402E-91E5-81673C4EBBD5Q38652938-5E4F06CF-E9EC-4A3C-94D8-BB8C96A1C48FQ38844989-8365C376-FDEB-49AF-9EEB-A548AE0D9990Q39005851-B0883CD9-02D9-4AAF-B407-2D3DD0A80BA4Q39033250-333F11CA-3EDE-45C2-8E18-879B8C230093Q39423441-20C5FAE1-77A9-4173-9549-F8C06DDBD78AQ40406413-FFB2647D-73E5-4F5A-A1F9-FF2D76C73E0BQ40634635-3A1E6FF1-6182-4C0E-A836-CFC618A1C550Q43455255-73C7B8D3-B5B7-462D-8F3D-1B83030EA81BQ43882808-233DFBA1-3459-4B9B-B90A-CBCEA8013C34Q43922282-816483B5-4E11-4E0D-9D74-9D140143D201Q44008848-89C7CEF6-BF34-411B-9F33-F812242C15BDQ44366685-2225A4DC-7D4F-4F21-A735-BC84B7D4E87EQ44479215-0C2FC3B7-CE8F-45D0-9C57-0060E98E35E2Q45164926-FBD67163-01A3-437F-AFBB-E0CFEFD3EA24Q45199593-06C3B1DA-E9E1-4190-91E1-3C1F2E6FAA53Q46150827-C9B22CE0-59E1-4E0F-BB96-F6D69F174F68Q48391870-757925EE-6D02-4342-B530-D566FD5C9D8FQ48594102-162F2E7D-B021-4F80-8DB7-3B9494F06B31Q49885524-6CCAEC95-99B7-4267-99F0-363C55A5ACAFQ49888258-75AB2664-3D8A-444C-9F68-1A2D93FE3277Q51027555-FFF4BCE6-6F80-4E60-AE37-7687AA5EE763Q51151745-E04502D7-70AF-4EA9-82EE-CD2DD4CC9003Q51545045-4C501463-71B9-4FD7-BE00-01A93A9DBE4CQ53468821-ADD1CC01-4BD2-403A-87C8-CF672593AF16Q53662506-C1287AB1-10B5-4A13-BF2A-DC439B55F582Q57259568-DC2CC1C0-6A13-4DE8-9644-3FBFF423562EQ57259605-3F76420B-887A-4678-82F0-DFC5E9F7A19EQ64882335-9901F522-BB1C-4A4C-B8A4-888083A54C11Q73001129-043FC14B-08DE-4DB8-B6AE-19E7EECD0D3CQ73334051-D892E364-024E-4ABB-B44B-379090C6A5A0Q73665060-3B5A8563-07FE-48A7-9187-93C9C01C628B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Patrick Jourdain
@ast
Patrick Jourdain
@en
Patrick Jourdain
@es
Patrick Jourdain
@nl
type
label
Patrick Jourdain
@ast
Patrick Jourdain
@en
Patrick Jourdain
@es
Patrick Jourdain
@nl
prefLabel
Patrick Jourdain
@ast
Patrick Jourdain
@en
Patrick Jourdain
@es
Patrick Jourdain
@nl
P106
P31
P496
0000-0002-5202-6902